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Yeast Rtt109 promotes nucleosome assembly and
genome stability by acetylating K9, K27, and K56 of
histone H3 through interaction with either of two
distinct histone chaperones, Vps75 or Asf1. We
report the crystal structure of an Rtt109-AcCoA/
Vps75 complex revealing an elongated Vps75 homo-
dimer bound to two globular Rtt109 molecules to
form a symmetrical holoenzyme with a 12 A˚ diam-
eter central hole. Vps75 and Rtt109 residues that
mediate complex formation in the crystals are also
important for Rtt109-Vps75 interaction and H3K9/
K27 acetylation both in vitro and in yeast cells. The
same Rtt109 residues do not participate in Asf1-
mediated Rtt109 acetylation in vitro or H3K56 acety-
lation in yeast cells, demonstrating that Asf1 and
Vps75 dictate Rtt109 substrate specificity through
distinct mechanisms. These studies also suggest
that Vps75 binding stimulates Rtt109 catalytic
activity by appropriately presenting the H3-H4
substrate within the central cavity of the holoenzyme
to promote H3K9/K27 acetylation of new histones
before deposition.
INTRODUCTION
Histone acetyltransferase (HAT) enzymes modify histone lysine
residues to modulate various DNA-templated processes
including replication, transcription, and DNA repair. Rtt109 is
a fungal-specific HAT that acetylates lysine 56 on newly synthe-
sized histone H3 (H3K56) during S-phase to mediate nucleo-
some assembly during DNA replication and DNA repair. Rtt109
is also important for cell survival after treatment with a number
of genotoxic agents (Collins et al., 2007; Driscoll et al., 2007;Structure 19, 22Han et al., 2007a; Tsubota et al., 2007). Together with Gcn5,
Rtt109 was more recently shown to contribute to the acetylation
of histone H3K9 (Fillingham et al., 2008) and H3K27 (Burgess
et al., 2010). Rtt109 harbors very low acetyltransferase activity
on its own (Driscoll et al., 2007; Tsubota et al., 2007), but its
activity is stimulated by association with either of the histone
chaperone proteins Asf1 or Vps75 (Albaugh et al., 2010; Bernd-
sen et al., 2008; Han et al., 2007b, 2007c; Tsubota et al., 2007).
In vivo, Rtt109-mediated acetylation of H3K56 requires Asf1, an
evolutionarily conserved histone chaperone that binds to H3-H4
dimers (English et al., 2006), although Asf1 does not seem to
form a stable complex with Rtt109 in vitro (Driscoll et al., 2007;
Han et al., 2007b; Tsubota et al., 2007). In addition, both the
Asf1 and Vps75 histone chaperones contribute to H3K9 acetyla-
tion in vivo (Adkins et al., 2007; Berndsen et al., 2008; Fillingham
et al., 2008). Vps75 is a member of the NAP1 histone chaperone
family that binds to both (H3-H4)2 tetramers and H2A-H2B
dimers (Park et al., 2008; Selth and Svejstrup, 2007). The
Rtt109/Vps75 complex can also acetylate H3K56 in vitro (Bernd-
sen et al., 2008; Lin and Yuan, 2008; Tsubota et al., 2007), but
a vps75 null mutant shows no decrease in H3K56 acetylation
in vivo (Tsubota et al., 2007; Han et al., 2007c). Recently,
H3K56 acetylation has been observed to overlap strongly with
the binding of key pluripotency regulators at active and inactive
promoters in human embryonic stem cells (Xie et al., 2009), but
there have been conflicting reports about whether this modifica-
tion is mediated by the GCN5 (Tjeertes et al., 2009) or p300/CBP
HAT in association with ASF1 (Das et al., 2009).
Our group and others have reported on the X-ray crystal struc-
ture of Rtt109 (Lin and Yuan, 2008; Stavropoulos et al., 2008;
Tang et al., 2008a), leading to the unexpected observation that
Rtt109 is structurally related to p300/CBP, despite the lack of
significant sequence conservation. We and others have also
reported that Vps75 adopts a dimeric head-phone-like structure
(Berndsen et al., 2008; Park et al., 2008; Tang et al., 2008b) that is
distinct from the monomeric b sandwich fold of Asf1 (Daganzo,
2003; English et al., 2006). To obtain direct molecular insights
into how Rtt109 activity is modulated by the binding of histone1–231, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 221
Table 1. Data Collection and Refinement Statistics
Rtt109–AcCoA-Vps75(1-232) Complex
Peptide-Soaked Crystal
PDB ID 3Q33
Native Crystal
PDB ID 3Q35
Data collection
Space group P21212 P21212
Cell dimensions
a, b, c (A˚) 97.543, 119.570,
80.566
98.085, 119.001,
80.292
a, b, g () 90.0, 90.0, 90.0 90.0, 90.0, 90.0
Wavelength (A˚) 0.984 0.984
Resolution (A˚)a 50–2.75 (2.85–2.75) 50–3.3 (3.42–3.30)
Rsym 0.047 (0.363) 0.083 (0.427)
I/sI 26.1(2.4) 16.5 (3.6)
Completeness (%) 94.9 (78.1) 99.7 (97.2)
Redundancy 4.8 (3.8) 7.1 (6.2)
Refinement
Resolution (A˚) 50–2.8 50–3.3
No. reflections 22,879 14,631
Rwork/Rfree 0.191/0.253 0.207/0.248
No. atoms
Protein 5000/611 aa 4975/607 aa
H3 peptide 25/4 aa NONE
AcCoA 51/1 molecule 51/1 molecule
Ethylene glycol 4/1 molecule 4/1 molecule
Water 23 11
B-factors
Protein (R/V/H3) 81.9, 86.2, 85.3 89.3, 92.6
AcCoA/ethylene G 83.4/76.1 82.2/65.7
Water 64.1 46.8
Root-mean-square deviations
Bond lengths (A˚) 0.009 0.011
Bond angles () 1.154 1.309
a Values in parentheses are for the highest-resolution shell.
Structure
Structure of the Rtt109-AcCoA/Vps75 Complexchaperones, we now report on the X-ray crystal structure of an
Rtt109-AcCoA/Vps75 complex. We also present structure-
based mutagenesis, combined with biochemical and, enzymo-
logical data, and studies in yeast cells to derivemolecular insights
into the mechanism by which histone chaperones enhance and
mediate lysine-specific histone acetylation by Rtt109.
RESULTS
Rtt109/Vps75 Forms a Symmetrical Ring
with a 2:2 Stoichiometry
We prepared the Rtt109/Vps75 complex by coexpressing the
full-lengthRtt109proteinwith the coredomainof Vps75 (residues
1–232) in bacteria and purifying the tightly associated complex to
homogeneity using a combination of affinity, ion exchange, and
size exclusion chromatography. The protein complex wasmixed
with acetyl coenzyme A (AcCoA) and crystals were obtained in
spacegroup P21212 (native crystal) that diffracted to 3.3 A˚ resolu-
tion. Soaking of these crystals with a 14-amino acid peptide
centered around H3K9 (peptide-soaked crystal) produced
crystals that diffracted to a higher resolution of 2.8 A˚, but with
the peptide bound in a nonphysiologically relevant manner, but
otherwise essentially identical to the native Rtt109/Vps75
complex (see Figure S1 and Supplemental Experimental Proce-
dures available online). Because of its higher resolution, the
peptide-soaked Rtt109/Vps75 complex is used for further
analysis as described below. Within the crystal lattice, each
asymmetric unit contains one molecule each of Rtt109 bound
to AcCoA and Vps75, related by a crystallographic 2-fold
symmetry axis to form the functional heterotetramer with two
boundAcCoAmolecules. The structurewas refined to 2.8 A˚ reso-
lutionwith refinement statistics ofRwork = 0.191 (Rfree =0.253) and
geometrical parameters of root-mean-square deviation
(RMSD)bond length = 0.009 A˚ andRMSDbond angle = 1.154
 (Table 1).
The Rtt109-AcCoA/Vps75 complex reveals that the obligate
Vps75 homodimeric headphone-like structure, which contains
an elongated helical dimerization domain and globular earmuff
domains at each end of the dimerization domain, is bound on
opposite ends by two globular Rtt109 molecules to form
a symmetrical ring with a hole of 12 A˚ diameter (Figure 1).
The two Rtt109 subunits make extensive sequence-specific
contacts with the Vps75 dimer burying a solvent-accessible
surface (SAS) of 3725 A˚2 for each Rtt109-Vps75 pair, whereas
the two Rtt109 subunits make more modest and nonspecific
interactions with each other burying 1736 A˚2 of SAS. Each
Rtt109 subunit contacts the Vps75 dimer in two distinct regions.
The Rtt109-a8-a9 helices pack against the a2-a5 helices of the
Vps75 earmuff domain (burying 1982 A˚2 of SAS) and the
Rtt109 130–179 segment reaches around the Vps75 earmuff
domain to engage the Vps75 dimerization helices (burying
1743 A˚2 of SAS). The less extensive Rtt109-Rtt109 interface
primarily involves nonspecific contacts between the a7-b7 loops
of both molecules.
The Tightly Associated Rtt109-AcCoA/Vps75 Complex
Does Not Involve Significant Structural Changes in
Rtt109 or Vps75
The Rtt109-a8-a9 helices make predominantly hydrogen-bond
contacts to the a2-a5 helices of the Vps75 earmuff domain (Fig-222 Structure 19, 221–231, February 9, 2011 ª2011 Elsevier Ltd All rure 2A). Specifically, lysines 356 and 363 of Rtt109-a8 hydrogen
bond toGln64 of Vps75-a2 andAsn70 of Vps75-a3, respectively;
and Tyr364 of Rtt109-a8 makes van der Waals contact to Ala74
of Vps75-a4. Glu374, Glu378, and Arg390 of Rtt109-a9 make
salt-bridges to Arg173 and Lys177 of Vps75-a5, and Arg73
and Asp81 of Vps75-a4, respectively. Asn382 of Rtt109-a9
also makes a hydrogen bond to the backbone NH of Ala74,
and Leu389 of Rtt109-a9 makes van der Waals contacts to
Phe77 and the aliphatic region of Lys78 of Vps75-a4.
The 130–179 segment of Rtt109 is not conserved in all species
of yeast (Figure S2) and is either absent (deleted from the crystal-
lized protein) or disordered in previously reported Rtt109 struc-
tures (Lin and Yuan, 2008; Tang et al., 2008a). However, in the
Rtt109-AcCoA/Vps75 complex, this segment contains a well-
ordered central helix from residues 144–155 (called a3i as it
forms in between the previously defined a3 and a4 helices)
and surrounding loop regions that are partially ordered (Fig-
ure 2B). The Rtt109-a3i helix contacts both Vps75 subunits
through a combination of hydrogen bonding and van der Waalsights reserved
Figure 1. Overall Structure of the Rtt109/Vps75 Complex
(A and C) Two orthogonal views of the Rtt109/Vps75 complex. The obligate
Vps75 homodimer is shown with subunits in blue and green and the two
Rtt109 subunits are shown in purple and orange. The proteins are shown in
cartoon representation. The two interfaces that are boxed are shown inmolec-
ular detail in Figures 2A and 2B.
(B) and (D) are the same views as (A) and (C), respectively, but shown in surface
representation.
Structure
Structure of the Rtt109-AcCoA/Vps75 Complexinteractions. Arg154 of Rtt109-a3i forms a salt bridge with
Asp222 of Vps75-a8, a residue at the base of the Vps75 earmuff
domain that also forms two main-chain H-bonds with Ile138 of
Rtt109. In addition, Arg149 of Rtt109-a3i forms a salt-bridge
with Glu23 of Vps75-a10 from the opposite subunit. Other resi-
dues of Rtt109-a3i also contact the a8 and a10 helices of the
Vps75 earmuff and dimerization domains, respectively, through
mostly van der Waals interactions (Figure 2B). Specifically,
Ala145, Leu148, Ile150, Leu151, and Ala152 of Rtt109-a3i and
Ile138 within the preceding loop form a hydrophobic network
with a cluster of Vps75-a8 (Val213 and Tyr216) and a10 (Phe15,
Leu16, and Ala19) residues.
Except for the 130–179 segment of the Rtt109-CoA/Vps75
complex, the uncomplexed Rtt109 and Vps75 proteins superim-
pose well with no significant structural changes and RMS devia-
tions for all ordered Ca atoms of 0.75 A˚ and 1.14 A˚, respectively.
Strikingly, even the Rtt109 active site residues Tyr199 and
Trp222, the bound AcCoA and the acetylated Lys290 superim-
pose well (Figure 2C). This observation suggests that Vps75-
mediated stimulation of Rtt109 HAT activity does not involve
an alteration of Rtt109 conformation or its active site on Vps75
binding. Vps75 binding to Rtt109 strongly stimulates the kcat
(100-fold) and has little effect on the Km for H3 substrates
(Berndsen et al., 2008). Based on this and the structures of the
holoenzyme and free Rtt109, we propose that Vps75 stimulatesStructure 19, 22Rtt109 HAT activity by productively positioning specific lysine
residues of histone H3 within the Rtt109 active site.
Stable Rtt109-Vps75 Interaction Is Required for Optimal
HAT Activation
To determine the functional significance of the Rtt109-Vps75
contacts that are observed in the crystal structure of the
complex, we carried out structure-based mutagenesis of
Rtt109 followed by Rtt109-Vps75 interaction and enzymatic
assays using recombinant (H3-H4)2 tetramer as a substrate.
Given that in the Rtt109-AcCoA/Vps75 complex, one Rtt109
molecule contacts both Vps75 subunits, we first asked whether
Vps75 dimerization is required for its ability to stimulate Rtt109
HAT activity. For this purpose, we prepared the Vps75-
(C21E,V25S,I28E,V32E) mutant previously shown to produce
monomeric Vps75 (Berndsen et al., 2008) and found that it is
strongly defective in binding to Rtt109 (Figure 3A) as well as in
stimulating Rtt109 HAT activity (Figure 3B). This result confirms
that Vps75 dimer formation is required for Rtt109 interaction
and optimal stimulation of Rtt109 HAT activity.
As Rtt109 interacts with Vps75 through two distinct surfaces
(Figure 2; Figure S2A), we also asked whether both surfaces
are required for Rtt109 function in vitro. We have previously
reported mutagenesis data implicating two distinct Vps75
surfaces for Rtt109 interaction (Tang et al., 2008b). Specifically,
we showed that the Vps75-(E218K,D222K) mutant abolishes
Rtt109 interaction, whereas the distal Vps75-(R173E,K177E)
mutant and Vps75-D(167-178) deletion greatly compromise
Rtt109 interaction. This data is consistent with the Rtt109-Ac-
Coa/Vps75 structure reported here. Vps75-Asp222 and
-Glu218 interact with the 130–179 segment of Rtt109 (Figure 2B),
whereas Vps75-Arg173 and -Lys177 interact with the a8-a9
region of Rtt109. As shown in Figure 3A, another mutation,
Vps75-(R73D,A74D), that disrupts the interface with Rtt109-
a8-a9, completely abolishes interaction with Rtt109. Vps75
mutations that reduce its interaction with Rtt109 in pull-down
assays also show a diminished ability to stimulate Rtt109 HAT
activity (Figure 3B). In particular, the Rtt109 binding defective
mutants, Vps75-(R73D, A74D), -(R173E,K177E), and -(E218K,
D222K) each show a reduced ability to stimulate Rtt109 HAT
activity relative to the wild-type Vps75 protein.
Mutation of Rtt109 residues that contact Vps75 also show
a defect in pull-down assays and Vps75-mediated stimulation
of Rtt109 HAT activity. As shown in Figure 3C, removal of the
130–179 segment of Rtt109 that contacts the Vps75 dimerization
domain, or substitution mutations of Vps75-interacting residues
in this segment, Rtt109-(L148D) or Rtt109-(I150D,L151D),
abolish Vps75 binding. Similarly, combined substitution muta-
tions in the Rtt109 a8-a9 residues that mediate contacts with
the Vps75 earmuff domain, Rtt109-(E378R,N382R) and Rtt109-
(R355E,K356E), also diminish Vps75 binding. Correlating with
the reduced Rtt109-Vps75 interaction, each of these Rtt109
mutants show reduced Vps75-stimulated HAT activity relative
to wild-type Rtt109 (Figure 3D). Taken together, these studies
indicate that the 130–179 segment and a8-a9 region of Rtt109
(Figure S2B) are both required for optimal Vps75 interaction
and HAT activity stimulation.
Comparison of free and Vps75-bound Rtt109 structures
suggests that the Rtt109 130–179 segment is only ordered in1–231, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 223
Figure 2. Details of the Two Rtt109-Vps75 Interac-
tion Surfaces
(A) The Rtt109 interface with the Vps75 earmuff domain is
shown in cartoon representation. Residues that mediate
protein-protein interaction or near the protein-protein
interface and targeted for mutagenesis are shown as stick
models in CPK coloring. Hydrogen bonds are indicated as
yellow dashed lines. The orientation is similar to Figure 1A
(boxed interface 1).
(B) The Rtt109 interface with the Vps75 dimerization
domain rendered as described above.
(C) A superposition of the Rtt109 active site in the apo- and
Vps75-bound forms is shown in cartoon representation.
Active site residues in the insert are shown as stick models
in CPK coloring (Lys290 is too far away to be included in
the inset).
Structure
Structure of the Rtt109-AcCoA/Vps75 Complexthe presence of Vps75 (Lin and Yuan, 2008; Tang et al., 2008a).
To confirm that this is also true in solution, we probed the proteo-
lytic sensitivity of Rtt109 as a function of Vps75 binding. To carry
out these studies, we prepared three recombinant Rtt109
proteins: wild-type Rtt109, Rtt109-D(130–179) in which residues
130–179 are removed and Rtt109-(L148D), a mutant defective in
Vps75 binding. As shown in Figure 3E, in the absence of Vps75,
Rtt109-wt and Rtt109-(L148D) are readily cleaved by trypsin,
whereas the Rtt109-D(130–179) mutant is significantly more
protease resistant. In the presence of Vps75, however, Rtt109-
wt is protected from proteolysis. In contrast, the Rtt109-
(L148D) mutant that cannot bind to Vps75 but retains the
130–179 segment, remains sensitive to trypsin even in the pres-
ence of Vps75. Taken together, these studies reveal that, in the
absence of Vps75, Rtt109 is highly susceptible to trypsin
cleavage, and this appears to be nucleated by the 130–179
segment of Rtt109. Interestingly, a recent report has shown
that the in vivo stability of Rtt109 is compromised in cells lacking
Vps75 (Fillingham et al., 2008). Based on the structural and
biochemical results reported here, we hypothesize that the
reduced stability of Rtt109 in the absence of Vps75 in vivo corre-
lates with the exposure of the 130179 segment, which renders
Rtt109 susceptible to degradation. Interestingly, Rtt109 ortho-
logs from several yeast species do not contain the 130–179
region (Figure S2B), suggesting that these speciesmay compen-
sate for the absence of the 130–179 segment by using other224 Structure 19, 221–231, February 9, 2011 ª2011 Elsevier Ltd All rD
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Kights reservedsurfaces of Rtt109 to stabilize its interaction with
Vps75. Alternatively, these species may not use
Vps75 to stimulate the HAT activity of Rtt109.
Asf1 and Vps75 Stimulate Rtt109 HAT
Activity through Distinct Mechanisms
Given that Rtt109 HAT activity can be stimu-
lated by both the Vps75 and Asf1 histone
chaperones, we asked whether the regions of
Rtt109 that mediate Vps75 interaction and stim-
ulation of HAT activity are also used for Asf1-
mediated Rtt109 stimulation. To determine
whether the stimulation of HAT activity by Asf1
requires the 130–179 segment of Rtt109, we
assayed the acetyltransferase activity of
Rtt109-wt and two Rtt109 mutants, Rtt109-(130–179) and Rtt109-(L148D), in the presence or absence of
sf1. As shown in Figure 3D, Asf1 enhances the HAT activity of
e Rtt109-D(130–179) and Rtt109-(L148D) mutants as effec-
vely if not better than the wild-type protein, demonstrating
at Asf1 does not use the 130–179 segment of Rtt109 to stimu-
te its HAT activity. This is in striking contrast to Vps75, which
oorly increases the HAT activity of Rtt109-D(130–179) and
tt109-(L148D) (Figure 3D). In addition, Rtt109 a8-a9 mutations
at significantly cripple stimulation of Rtt109 HAT activity by
ps75 do not show a defect in Asf1-stimulated HAT activity (Fig-
re 3D). These include Rtt109-(R355E,K356E), Rtt109-(E374R),
tt109-(E378R) and Rtt109-(E378R,N382R). Taken together,
ese results suggest that Vps75 and Asf1 stimulate Rtt109
AT activity through distinct mechanisms.
To further probe the lysine substrate specificity of the Rtt109/
ps75 complex, we prepared histone H3 mutants that contain
ither K9R/K27R (K56 is available for acetylation), K27R/K56R
9 is available for acetylation) or K9R/K56R (K27 is available
r acetylation) substitutions in the context of the (H3-H4)2
tramer and used them as substrates for Rtt109/Vps75. Kinetic
nalysis revealed that the wild-type Rtt109/Vps75 complex
xhibits comparable catalytic efficiency toward the wild-type
nd H3-K27R/K56R mutant histone substrates but significant
efects toward any of the histone substrates harboring a K9R
utation, showing a decrease in kcat of 10-fold and elevated
m values (Figure 3F; Figure S3A). This data is consistent with
AB
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Figure 3. Identification and Characterization of Key Residues that Mediate Rtt109-Vps75 Complex Formation, Rtt109 HAT Stimulation by
Vps75 or Asf1, and H3 Substrate Specificity by Mutagenesis, Pull-Down, and Enzymatic Assays
(A) Pull-down studies of Vps75-wt and mutants by GST-Rtt109-wt. Published mutants (**) were included for comparison (Tang et al., 2008b). Vps75-(monomeric)
number is Vps5-(C21E,V25S,I28E,V32E) (Berndsen et al., 2008).
(B) HAT assays were performed with (H3-H4)2 tetramer and [
14C]AcCoA substrates and complexes of GST-Rtt109-wt with Vps75-wt and mutants.
(C) Pull-down studies of Vps75-wt by GST-Rtt109-wt and mutants. A published mutant (**) was included for comparison (Tang et al., 2008b).
(D) Enzymatic studies of GST-Rtt109-wt and mutants in the presence of Vps75-wt or yAsf1N (1–154). HAT assays were performed with (H3-H4)2 tetramer and
[14C]AcCoA substrates.
(E) Limited proteolysis of Rtt109/Vps75 complexes containing wild-type, mutant or truncated forms of Rtt109. Reaction products after 10 min of trypsin digestion
are shown. A 30-min reaction showed a nearly identical pattern of digestion.
(F) Catalytic rates (kcat) were measured for Rtt109-WT and Rtt109-(R292E) using the following substrates in the context of the (H3-H4)2 tetramer: H3-WT,
H3-(K9R/K56R), H3-(K27/K56R), H3-(K9/K27R), andH3-(K9R, K27/K56R) (Figure S3). All parameters were determined by a nonlinear regression fit to theMichae-
lis-Menten equation (see Experimental Procedures).
Structure
Structure of the Rtt109-AcCoA/Vps75 Complexquantitative MS and Edman sequencing analyses of the reaction
products obtained with wild-type (H3-H4)2, which showed that
the Rtt109/Vps75 complex preferentially acetylates H3K9 over
H3K56 and other acetylation sites in the N-terminal tail of H3
(Figure S3D).
In our survey of Rtt109 mutants that exhibit reduced HAT
activity in the presence of histone chaperones, wewere intrigued
by an Rtt109-(R292E) mutant that did not affect Rtt109/Vps75Structure 19, 22complex formation (Figure 3C) and only had a modest effect
on Vps75-stimulated H3 acetylation, but showed more dramatic
defects in Asf1-stimulated acetylation (Figure 3D). To further
probe this mutation, we carried out more detailed kinetics on
the Rtt109/Asf1 and Rtt109-(R292E)/Asf1 complexes using the
wild-type (H3-H4)2 substrate. We found that, in contrast to
wild-type Rtt109/Vps75 and Rtt109-(R292E)/Vps75 that acety-
late the (H3-H4)2 substrate with comparable activity (<2-fold1–231, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 225
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Figure 4. Histone Binding by the Rtt109-AcCoA/
Vps75 Complex
(A and B) Orthogonal surface representations of the
Rtt109-AcCoA/Vps75 complex reveal a high degree of
sequence conservation within the interior of the ring-
shaped complex. The color-coding indicates the degree
of conservation as shown in the bar key, with sequence
conservation information derived from previously pub-
lished alignments (Tang et al., 2008a, 2008b). For clarity,
only one Rtt109molecule and half of the Vps75 homodimer
are shown (gray patch represents the cross section at
point of omission). The orientation of (A) is the same as in
Figure S2A.
(C) The exterior surface of the ring-shaped Rtt109/Vps75
complex shows a low degree of sequence conservation.
(D) Location of Rtt109 (Arg194 and Glu368) and Vps75
(Asp198, Glu206, and Glu207) residues whose mutation
decreases HAT activity (E). These residues are not involved
in mediating Rtt109-Vps75 interaction and do not appear
to be part of the active site and, therefore, are suggested
to participate in histone binding. The view is as in (A).
(E) Summary of kinetic parameters of selected Rtt109 and
Vps75 mutants within the ring interior of the Rtt109-Ac-
CoA/Vps75 complex (Figure S4). All parameters were
determined by a nonlinear regression fit to the classical Mi-
chaelis-Menten equation (see Experimental Procedures).
N.D.: not determined due to experimental considerations.
Structure
Structure of the Rtt109-AcCoA/Vps75 Complexdecrease in kcat/Km) and similar activity profiles for each of the
substrates bearing H3 mutants (Figure 3F; Figure S3B), the
Rtt109-(R292E)/Asf1 mutant shows about a 45-fold decrease
in kcat/Km for the (H3-H4)2 substrate relative to wild-type
Rtt109/Asf1 (Figure 3F; Figure S3C). This observation demon-
strates that residue Rtt109-R292 plays a more important role in
Asf1- over Vps75-mediated Rtt109 acetylation of histone H3.
Histone Substrates Bind within the Interior
of the Rtt109-AcCoA/Vps75 Ring
The observation that the acetyl group of AcCoA and the active
site residues of Rtt109 are facing toward the interior of the ring
structure implies that the histone substrate is bound in the inte-
rior of the ring-shaped Rtt109-AcCoA/Vps75 complex. This
hypothesis is supported by amapping of sequence conservation
onto the surfaces of both Rtt109 and Vps75, which reveals that
the most highly conserved surfaces of Rtt109 and Vps75 are
brought together in the interior of the ring (Figures 4A and 4B).
In contrast, the exterior surface of the complex shows relatively
poor sequence conservation (Figure 4C).226 Structure 19, 221–231, February 9, 2011 ª2011 Elsevier Ltd All rights reservedWe also identified several conserved and
solvent exposed Vps75 and Rtt109 residues
within the ring that result in reduced HAT activity
when mutated (Figures 3B, 3D, and 4D). These
mutants included Rtt109-(R194E), Rtt109-
(E368R), and Rtt109-(EEYD368RRYR), as well
as Vps75-(E206K,E207K). To determine the
histone acetylation defects of these mutants
more accurately, we determined their steady-
state kinetic parameters in the presence of
a large excess (presumed saturating) of Ac-CoA
(Figure 4E; Figure S4). This analysis revealed thatthe Vps75-(E206K,E207K) mutant predominantly has a histone
tetramer Km defect (>10-fold), whereas the other mutants have
defects in kcat of between 4- and 70-fold. Although the Km defect
of the Vps75-(E206K,E207K) mutant likely reflects a defect in
histone binding, the kcat defect of the other mutants could reflect
a destabilization of the transition state of the acetylation reaction.
Given that themutated residues are not near the active site of the
enzyme and are not involved in Rtt109/Vps75 interaction, we
propose that they mediate correct positioning of the histone H3
substrate in the active site for optimal acetylation. This proposal
is consistentwith our structural observation that Vps75binding to
Rtt109 does not significantly alter the Rtt109 active site (Fig-
ure 2C), as well as a previous report showing that Vps75 binding
stimulates Rtt109 activity by elevating the kcat, rather than by
reducing the Km for the H3 substrate (Berndsen et al., 2008).
Taken together, these data further support the role of the interior
of the ring-shaped complex in binding the histone substrate in
a manner that is productive for H3 acetylation.
It has been reported that a truncation of the C-terminal acidic
tail of Vps75 (residues 224–264) impairs its ability to activate
Structure
Structure of the Rtt109-AcCoA/Vps75 ComplexRtt109 without affecting Vps75 binding to Rtt109 (Park et al.,
2008). Because we found Vps75 residues as C-terminal as
Asp225 are involved in Rtt109 interaction, we asked how the
longer fragment (residues 1–232) used in our structure determi-
nation may impact Rtt109 HAT activity. To this end, we
compared the Rtt109 activation capabilities of Vps75-wt,
Vps75-(1–232), and Vps75-(1–223). We found that Vps75-(1–
232) and Vps75-(1–223) activate Rtt109 to similar levels, and
with an 4-fold reduced rate relative to full-length Vps75 (Fig-
ure 3B). These results suggest that Vps75 residues C-terminal
to Leu232 are required for optimal activation of Rtt109. Because
the last ordered residue of Vps75 in the structure of the complex,
Glu226, points toward the interior of the ring, we propose that the
Vps75 C-terminal acidic tail may also be in position to associate
with histones bound within the ring-shaped enzyme complex.
Mutations that Decrease Rtt109/Vps75 HAT Activity
In Vitro Reduce H3K9 and H3K27, but Not H3K56
Acetylation In Vivo
In vitro, the Rtt109/Vps75 holoenzyme cannot acetylate nucleo-
somes (Han et al., 2007c; Tsubota et al., 2007), suggesting that it
may exclusively act on newly synthesized histones before their
deposition onto DNA. Among the five acetylatable lysine resi-
dues in the N-terminal tail of H3, lysines K9 and K27 were found
to be the most extensively acetylated after a short pulse of
[3H]-lysine in Saccharomyces cerevisiae (Kuo et al., 1996).
Furthermore, in contrast to H3K56 acetylation, which is entirely
dependent on Rtt109 and Asf1 (Driscoll et al., 2007; Drogaris
et al., 2008; Han et al., 2007a; Tsubota et al., 2007), both Gcn5
and Rtt109-Vps75 contribute to H3K9 and H3K27 acetylation
in vivo (Berndsen et al., 2008; Burgess et al., 2010; Fillingham
et al., 2008).
To characterize the effects of the structure-based Rtt109
mutations in vivo, we first validated our assays by monitoring
H3K9/K27 and H3K56 acetylation in strains where selected
HAT genes were deleted. Based on mass spectrometry (MS),
H3K9 and H3K27 acetylation is abundant in vivo, with 20%
of H3 molecules acetylated at K9 and K27 in wild-type cells
(Figures 5B and 5C). As judged by MS, the levels of H3K9 and
H3K27 acetylation were considerably reduced, but not
completely abolished in gcn5 single mutants, whereas H3K56
acetylation was as abundant as in wild-type cells (Figures 5A–
5C). In contrast, essentially no H3K9 or H3K27 acetylation
remained in gcn5D vps75D or gcn5D rtt109D double mutants
and, consistent with previous reports, the rtt109D mutation
essentially abolished H3K56 acetylation (Figures 5A–5C) (Dris-
coll et al., 2007; Han et al., 2007b). As judged by MS, a vps75
null mutation did not significantly cripple acetylation of H3K14,
H3K18, or H3K23, whereas H3K18 was essentially abolished in
gcn5 single mutants (data not shown). These results demon-
strate that, in vivo, the Rtt109/Vps75 enzyme functionally overlap
with Gcn5 to acetylate H3K9 and H3K27, whereas Rtt109 and
Asf1 cooperate to promote H3K56 acetylation.
Importantly, when introduced into either gcn5D rtt109D or
gcn5D vps75D double mutants, low copy plasmids expressing
wild-type Rtt109-Flag or Vps75-Flag, respectively, from their
natural promoters, restored H3K9, K27, and K56 acetylation
(Figures 5A–5H). This provided assays to monitor the effects of
structure-based Rtt109 mutations on histone acetylation. TheStructure 19, 22structure-based Rtt109 mutants that we tested in vivo showed
defects in H3K9 and K27 acetylation, with the Rtt109-(L148D)
and Rtt109-(E378R,N382R) mutants being the most defective
(Figures 5E–5G and data not shown). Therefore, we focused
our in vivo studies on these two Rtt109 mutants. Based on MS
and immunoblotting, the Rtt109-(L148D) and Rtt109-
(E378R,N382R) were defective in H3K9/K27 acetylation, but
not H3K56 acetylation in vivo (Figures 5D–5G). As judged by
MS and immunoblotting, the Rtt109-(L148D) mutation abolished
its interaction with Vps75 whereas the Rtt109-(E378R,N382R)
mutant showed residual binding to Vps75 in vivo (Figures 6A
and 6B). Consistent with the greater sensitivity of Rtt109-
L148D and Rtt109-E378R,N382R to mutations, these residues
are located within the Rtt109 (130–179) segment and a8-a9 helix
region of Rtt109, respectively, whichmediate contacts to the two
distinct binding surfaces on Vps75 (Figure 2). In the absence of
Vps75, Rtt109 has been reported to be less stable than in wild-
type cells (Fillingham et al., 2008). In agreement with its strong
defect in interaction with Vps75, the Rtt109-(L148D) mutation
(and to a lesser extent the Rtt109-(E378R,N382R) mutation)
destabilized the protein to an extent similar to that observed in
a vps75 null mutant even though each of the mutant proteins
are expressed at similar steady-state levels (Figure 6D).
We also determined the effects of Vps75 mutations on histone
acetylation and complex formation in vivo. In keeping with the
structure of the holoenzyme (Figure 2), the Vps75-(R173E,
K177E) and Vps75-(E218K,D222K) mutations reduced the inter-
action of Vps75 mutants with Rtt109 both in vitro (Figure 3A) and
in vivo (Figure 6C). In contrast, mutation of residues E206 and
E207, which line the central cavity of the Rtt109/Vps75 holoen-
zyme and are not involved in interaction with Rtt109 (Figures
3A and 4D), only has a mild effect on the interaction of Rtt109
and Vps75 in vivo (Figure 6C). However, compared with WT
Vps75, all three Vps75 mutations reduced H3K9/K27 acetylation
without perturbing H3K56 acetylation in vivo (Figure 5H). These
results taken together, demonstrate that mutations that
decrease Rtt109/Vps75 interaction and H3K9 but not H3K56
acetyltransferase activity in vitro correlates with similar activities
in vivo.
Mutations that Decrease the H3K9 HAT Activity
of the Rtt109/Vps75 Complex In Vitro and In Vivo
Are Not Sufficient to Confer Phenotypes Associated
with Defects in Nucleosome Assembly
In vivo, mutations that cripple the acetylation of new histones or
interfere with replication-coupled nucleosome assembly confer
sensitivity to genotoxic agents and defects in cell proliferation
and heterochromatin-mediated gene silencing (Burgess et al.,
2010; Driscoll et al., 2007; Han et al., 2007a, 2007b; Li et al.,
2008; Tsubota et al., 2007). This is indeed what we observed in
rtt109 single and rtt109 gcn5 double mutants (Figures S5 and
S6). In rtt109D gcn5D double mutants, H3K9/K27 in the
N-terminal tail and H3K56 acetylation are essentially abolished
(Figures 5A–5C). However, none of our structure-based muta-
tions that selectively disrupt the structure and/or activity of the
Rtt109/Vps75 holoenzyme resulted in proliferation, genotoxic
agent sensitivity or heterochromatin-mediated silencing (Figures
S5A, S5B, and S6C). This was true even when structure-based
Rtt109/Vps75 mutations were combined with other mutations1–231, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 227
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Figure 5. In Vivo Analysis of Wild-Type and Mutant Forms of the Rtt109/Vps75 Holoenzyme
(A–F) Histone lysine specificity of gcn5, rtt109, and vps75 null mutants and selectedmutants that specifically target the integrity of the Rtt109/Vps75 holoenzyme
as determined bymass spectrometry. Total histones were purified from asynchronously growing cells and analyzed bymass spectrometry (Supplemental Exper-
imental Procedures) to determine the fraction of H3 molecules acetylated at K9, K27, and K56.
(G and H) Histone lysine specificity of selected Rtt109 and Vps75 mutants as determined by immunoblotting. 1.5-fold serial dilutions of whole-cell lysates (from
left to right) were probed by immunoblotting to determine the levels of H3K9, K27 and K56 acetylation in cells expressing Rtt109 or Vps75 mutants. The asterisk
points to a nonspecific band that is weakly detected by our anti-H3K9ac in H3K9R mutant cells (not shown).
(I) Effect of selected Rtt109 mutants on histone assembly. Complexes of CAF-1 and histones H3/H4 were affinity-purified from yeast cells to determine the
amounts of histones bound to CAF-1 in strains expressing Rtt109 mutants.
Structure
Structure of the Rtt109-AcCoA/Vps75 Complexthat should reduce the efficiency of the replication-coupled
nucleosome assembly pathway, such as null mutations in gcn5
(that reduces N-terminal acetylation of new H3 molecules
(Burgess et al., 2010), hat1 (an enzyme that acetylates new H4
molecules at lysines 5 and 12) (Kelly et al., 2000; Qin and Par-228 Structure 19, 221–231, February 9, 2011 ª2011 Elsevier Ltd All rthun, 2002), or rtt106 (a chaperone that binds to new H3/H4
molecules) (Huang et al., 2007) (Figures S5B and S6A-C). These
results suggested that the absence of the Rtt109/Vps75 enzyme
is not sufficient to confer a physiologically significant defect in
replication-coupled nucleosome assembly. To further confirmights reserved
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Figure 6. In Vivo Analysis of the Integrity of the Rtt109/Vps75 Holo-
enzyme as a Function of Structure-Based Mutations
(A and B) Effect of selected Rtt109 mutations on the Rtt109-Vps75 interaction.
Copurification of Rtt109 and Vps75 from strains expressing Rtt109
mutants was monitored by immunoblotting (A) or mass spectrometry (B),
see Supplemental Experimental Procedures). All the strains used in (A) contain
a wild-type chromosomal VPS75 gene and an additional plasmid encoding
a wild-type VPS75-HA gene.
(C) Effect of selected Vps75 mutations on the Rtt109-Vps75 interaction. Cop-
urification of Rtt109 and Vps75 from strains expressing Vps75 mutants was
monitored by immunoblotting.
(D) Stability of Rtt109 mutants. The stability of Rtt109 mutants was determined
by immunoblotting as a function of time after the addition of cycloheximide.
The top panel is a control showing the reduced stability of wild-type Rtt109
in cells that lack Vps75.
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Structure 19, 22this hypothesis, we affinity-purified chromatin assembly factor 1
(CAF-1) and determined by MS the amounts of histones bound
to CAF-1. CAF-1 is the prototypical replication-coupled nucleo-
some assembly factor (Kaufman et al., 1997) and cells where
H3K56 acetylation is impaired contain low amounts of H3/H4
bound to CAF-1 (Kaufman et al., 1997; Li et al., 2008). Consistent
with the fact that they do not confer any striking phenotype, the
Rtt109-(L148D) and Rtt109-(E378R,N382R) mutants did not
show any striking decrease in the amounts of H3/H4 bound to
CAF-1, even in cells lacking Gcn5 (Figure 5I). Taken together,
these studies show that the H3K9/K27 acetylation activity of
the Rtt109/Vps75 complex is not sufficient to confer phenotypes
associated with defects in nucleosome assembly.
DISCUSSION
The Rtt109 histone acetyltransferase promotes nucleosome
assembly and genome stability by acetylating K9, K27, and
K56 on new non-nucleosomal histone H3 molecules through
its interactions with either of two distinct histone chaperones,
Vps75 or Asf1. H3K9 acetylation, in particular, is evolutionarily
conserved from yeast to human cells and is the most prominent
site of acetylation in the N-terminal tail of new H3 molecules in
S. cerevisiae (Adkins et al., 2007; Kuo et al., 1996). Despite the
importance of the acetylation of new histones, the mechanism
and the molecular basis of chaperone-mediated histone lysine
acetylation specificity have gone largely unexplored.
To explore the mechanism by which histone chaperones
promote Rtt109 HAT activity and lysine specificity, we deter-
mined the X-ray crystal structure of an Rtt109-AcCoA/Vps75
complex that revealed a 2-fold symmetrical heterotetrameric
ring containing an interior cavity of12 A˚ diameter. Biochemical,
enzymatic, and in vivo studies further demonstrated that Rtt109-
Vps75 contacts observed in the crystals are important for
optimal H3K9/K27 but not H3K56 acetylation both in vitro and
in yeast cells. A comparison of the Rtt109-AcCoA/Vps75
complex with the free Rtt109 and Vps75 proteins also showed
that Vps75 binding to Rtt109 does not alter the Rtt109 active
site, suggesting that Vps75 binding stimulates Rtt109 catalytic
activity by appropriately presenting histone H3 for acetylation.
We also used information derived from the structure of the
Rtt109-AcCoA/Vps75 complex to demonstrate that Asf1 and
Vps75 stimulate the HAT activity of Rtt109 via different mecha-
nisms. Along with other groups, we previously reported the iden-
tification of residues generally important for Rtt109-mediated H3
acetylation, including Rtt109 residues Asp89, Tyr199, Trp222,
and Asp287 (Han et al., 2007b; Tang et al., 2008a; Tsubota
et al., 2007). In this study, we extended these findings to residues
that play more dedicated roles in Vps75-mediated activation of
Rtt109 for H3K9 acetylation. We showed that the 130–179
segment of Rtt109 and other residues that contribute to interac-
tion surfaces between Rtt109 and Vps75 play a particularly
important role in Vps75-dependent histone H3K9 acetylation
both in vitro and in yeast cells. We also showed that Rtt109-
R292 plays a more important role in Asf1-mediated histone
acetylation.
The structure of the Rtt109-AcCoA/Vps75 complex, together
with results from in vitro enzymological assays and analysis of
acetylation in yeast cells, also indicate that histone substrate1–231, February 9, 2011 ª2011 Elsevier Ltd All rights reserved 229
Structure
Structure of the Rtt109-AcCoA/Vps75 Complexbinding occurs within the interior surface of the ring-shaped
Rtt109/Vps75 complex. Three lines of evidence support this
model. First, the acetyl groups of the two Rtt109-bound AcCoA
cofactors in the complex point into the interior of the ring. Second,
the internal surface of the ring shows a much higher degree of
sequence conservation than theexterior. Third,wehave identified
severalRtt109andVps75substitutionmutationswithin the interior
of the ring that reduce histone H3 acetylation in vitro and H3K9/
K27 but not H3K56 acetylation in vivo. The 2:2 stoichiometry
and 2-fold symmetry of the complex are also consistent with the
observation that Vps75 preferentially binds (H3-H4)2 heterote-
tramers (Selth and Svejstrup, 2007) and strongly suggests that
both H3 molecules of the heterotetramer are acetylated for
histone deposition. In this way, the Vps75 histone chaperone
serves as a cofactor for Rtt109-mediated acetylation by both
appropriately positioning histone H3K9 for acetylation in the
Rtt109 active site and ensuring homogenous histone H3 acetyla-
tion before H3-H4 deposition into nascent chromatin.
The structure of the Rtt109-AcCoA/Vps75 complex also
enabled us to design Rtt109 and Vps75 separation-of-function
mutants. These mutations leave H3K56 acetylation unaffected,
but completely abolish the H3K9/K27 acetylation that remains
in gcn5D cells (Figures 5 and 6). Significantly, mutations that
selectively perturb the Rtt109/Vps75 enzyme do not exacerbate
the phenotypes of gcn5D cells nor do they exhibit phenotypes
that are commonly observed in mutants where replication-
coupled nucleosome assembly is defective. This is likely
because of the overlapping substrate specificity of Gcn5 and
Rtt109/Vps75 for H3K9/K27 and suggests that the Rtt109/
Vps75 complex contributes to, but is not essential for replica-
tion-coupled nucleosome assembly.
It is currently unclear why several distinct HATs (Hat1, Gcn5,
Rtt109/Vps75, Rtt109/Asf1, and possibly others) contribute to
the acetylation of new H3/H4 molecules. By analogy with isoen-
zymes, some of these HATs may not be functionally redundant
under certain growth or cellular stress conditions. However,
new tools will be necessary to determine whether this is the
case. Thus far, studies aimed at assigning functions to the acety-
lation of newly synthesized histones have beenmainly performed
by creating yeast strainswhereH3 andH4carry several lysine-to-
arginine mutations in the N-terminal tails. This experimental
strategy has been helpful, but suffers from two limitations. First,
thesemutations cripple the acetylation of both newly synthesized
and pre-existing histones and global disruption of histone acety-
lation interferes with transcription. Second, phenotypes that
result from histone lysine-to-arginine substitutions might be due
tomutations of the lysines, rather than the absenceof acetylation.
Rtt109/Vps75 isanenzyme thatexclusivelyacetylatesnon-nucle-
osomal histones at two specific residues in the N-terminal tails of
new H3 molecules. Therefore, the structure-based Rtt109
mutants described here, which are specifically defective in
H3K9/H3K27, but not H3K56 acetylation, may provide invaluable
tools to investigate the elusive function of the acetylation of the
N-terminal tails of newly synthesized histones.EXPERIMENTAL PROCEDURES
Individual Rtt109 and Vps75 proteins were engineered as GST fusions as
previously described (Tang et al., 2008a, 2008b), with theGSTmoiety removed230 Structure 19, 221–231, February 9, 2011 ª2011 Elsevier Ltd All rby TEV protease as necessary. Quick-change site-directedmutagenesis (Stra-
tagene) was used to introduce selected protein mutations. Recombinant
human 6His-ASF1a protein (Tang et al., 2006) and yeast (H3-H4)2 heterote-
tramer (Luger et al., 1999) were prepared as previously described. Yeast
6His-Asf1N(1–154) was cloned and prepared similarly to human ASF1a.
To produce complexes by coexpression, we subcloned DNAs encoding
full-length Vps75 (or a 1–232 fragment as used in crystallization) and full-length
Rtt109 proteins into the MCS1 and MCS2 sites, respectively, of a modified
6His-TEV-pCDF-Duet1 vector. Protein complexes were expressed in bacteria
and purified to homogeneity through a combination of Ni-affinity, TEV protease
cleavage, MonoQ anion exchange and Superdex S200 gel filtration
chromatography.
Rtt109-Vps75 pull-down assays were carried out with wild-type or mutant
GST-Rtt109 proteins bound to glutathione resin and untagged wild-type or
mutant forms of Vps75. After binding reactions, proteins retained on the resin
were resolved by SDS-PAGE. For enzymatic assays, we adapted the radioac-
tive HAT assay as previously described (Lau et al., 2000; Thompson et al.,
2001) using yeast (H3-H4)2 tetramer as a substrate. Proteolysis studies of
Rtt109 protein constructs were carried out with trypsin protease in the
absence or presence of stoichiometric amounts of full length Vps75 and termi-
nated by boiling the samples for resolution on SDS-PAGE.
Native crystals of the Rtt109-AcCoA/Vps75-(1–232) complex were obtained
using hanging-drop vapor-diffusion from a reservoir solution containing 10.0%
(v/v) PEG8000, 8% (v/v) ethylene glycol, and 100 mM HEPES pH7.5 buffer.
Peptide-soaked Rtt109-AcCoA/Vps75-(1–232) crystals were prepared by
soaking native crystals with 1 mM CoA and 1 mM of a H3K9 14-amino acid
peptide. The structure of the peptide-soaked Rtt109-AcCoA/Vps75-(1–232)
complex was determined to 2.8 A˚ resolution using molecular replacement
with Rtt109-D(130–179) (PDB ID 3D35) (Tang et al., 2008a) and a Vps75-
(1–232) monomer (PDB ID 3DM7) (Tang et al., 2008b) as search models. The
models were adjusted and refined to include the 130–179 segment of
Rtt109, AcCoA, and residues 11–14 of the H3K9 peptide [(NH2)A-R-T-K-Q-
T-A-R-K-S-T-G-G-K (CONH2)] (Figure S1; Table 1). Given that the peptide
does not make extensive protein contact and is located far from the active
site, we infer that this peptide-binding mode is not biologically relevant.
The final model, with the addition of 23 water molecules, was checked for
errors using composite simulated annealing omit maps (Table 1). The structure
of the native Rtt109-AcCoA/Vps75-(1–232) crystals was determined using the
refined peptide-soaked Rtt109-AcCoA/Vps75-(1–232) model and refined to
3.3 A˚ resolution (Table 1). Comparison of the two crystal forms reveals that
the presence of the H3K9 peptide does not alter the overall Rtt109-AcCoA/
Vps75 complex structure.
Yeast strains and plasmids to express Rtt109, as well as protocols to
monitor H3K9 andK56 acetylation by immunoblotting andmass spectrometry,
are described in detail in Table S1 and Supplemental Experimental
Procedures.
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Atomic coordinates and structure factors of the Rtt109-AcCoA/Vps75
complexes have been deposited in the Protein Data Bank with accession co-
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